Pre-Exposure Prophylaxis (PrEP): What Anesthesia Providers need to know about this Important HIV Prevention Tool-Presentation Slides

Presentation Slides

Pdf Summary

This document focuses on Pre-Exposure Prophylaxis (PrEP) as an important HIV prevention tool, particularly addressing anesthesia providers. It covers the current state of HIV and PrEP in the US, including statistics on HIV infections and the history of PrEP approval. The document highlights key medications, administration methods, pharmacology, and implications for anesthesia providers. It emphasizes the importance of understanding drug interactions, effects on the body, and anesthesia considerations related to PrEP.<br /><br />The text discusses the pharmacological interactions of PrEP, such as potential renal toxicity of Tenofovir, emphasizing the need for monitoring renal function. It also addresses adherence and efficacy, food and medication intake considerations, and the importance of labs monitoring for renal and hepatic functions.<br /><br />Furthermore, the document explores barriers and stigmas related to PrEP, suggesting creating a supportive environment and encouraging open communication between patients and healthcare providers to overcome challenges. It concludes with a call for detailed guidance on drug interactions, addressing stigma and misinformation, and the importance of future research in the perioperative care of individuals using PrEP.<br /><br />Overall, the document provides a comprehensive overview of PrEP, highlighting its impact on HIV prevention and the considerations anesthesia providers need to be aware of when caring for patients using PrEP.

Keywords

Pre-Exposure Prophylaxis

PrEP

HIV prevention

anesthesia providers

Tenofovir

drug interactions

renal toxicity

adherence

stigmas

perioperative care